Should the Carbon Footprint of Care be Taken into Account When Choosing a Treatment for Lymphoma? a Case Application on Mantle Cell Lymphoma

被引：0
|
作者：
Piffoux, Max [1 ]
Cabannes-Hamy, Aurelie [2 ]
Ben Souda, Hajer [2 ]
Hermine, Olivier [3 ,4 ]
Besson, Caroline [5 ]
机构：
[1] Serv Hematol, Lyon, France
[2] CH Versailles, Le Chesnay, France
[3] Univ Paris Cite, Imagine Inst, Paris, France
[4] Hop Necker Enfants Malad, Paris, France
[5] UVSQ, Saclay, CH Versailles, INSERM CESP, Le Chesnay, France
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-188890
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 20 条
  • [1] Mantle cell lymphoma of the Waldeyer ring: A case report and review of treatment modalities
    Diamantopoulou, K.
    Samaras, V.
    Eleftheriotis, V.
    Dimitriou, K.
    Tsopanomichalou, M.
    Christidis, K.
    VIRCHOWS ARCHIV, 2014, 465 : S86 - S86
  • [2] Bendamustine and rituximab for the treatment of relapsed indolent and mantle cell lymphoma: when timing of a study matters
    Falchi, Lorenzo
    Morales, Rita
    Ruella, Marco
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S590 - S594
  • [3] Ibrutinib in association with venetoclax for the treatment of mantle-cell lymphoma: a multicenter case series
    Fabbri, Alberto
    Cencini, Emanuele
    Congiu, Angela Giovanna
    Miglino, Maurizio
    Rigacci, Luigi
    Bocchia, Monica
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2020, 10 (06): : 355 - 359
  • [4] Rapid Treatment of Leukostasis in Leukemic Mantle Cell Lymphoma using Therapeutic Leukapheresis: A Case Report
    Xuan Duc Nguyen
    La Rosee, Paul
    Nebe, Thomas
    Klueter, Harald
    Buchheidt, Dieter
    THESCIENTIFICWORLDJOURNAL, 2011, 11 : 1554 - 1559
  • [5] IBRUTINIB IN MONOTHERAPY AS A TREATMENT OF RELAPSED MANTLE CELL LYMPHOMA IN THE CENTRAL NERVOUS SYSTEM. CASE REPORT
    Morales de la Plaza, A.
    Santero Garcia, M.
    Sebrango Sadia, A.
    HAEMATOLOGICA, 2018, 103 : 337 - 337
  • [6] Mantle cell lymphoma involving the colon (Multiple Lymphomatous Polyposis): A case report and review of treatment modalities
    Diamantopoulou, K.
    Samaras, V.
    Glava, C.
    Valaskatzi, A.
    Giovanitis, D.
    Kalantzakis, S.
    Levidou, G.
    Korkolopoulou, P.
    Goumas, K.
    VIRCHOWS ARCHIV, 2015, 467 : S205 - S205
  • [7] Clinical profile, treatment, and outcomes of patients with mantle cell lymphoma treated in a tertiary care center in South India
    Lokesh, Kadabur Nagendrappa
    Garg, Sunny
    Kuntegowdanahalli, Lakshmaiah Chinnagiriyappa
    Kanakasetty, Govinda Babu
    Srinivasamurthy, Premalata Chennagiri
    Rao, Suparna Ajit
    Jacob, Linu Abraham
    Dasappa, Loknatha
    Chikkadasappa, Suresh Babu Mallekavu
    Halleshappa, Rudresha Antapura
    Krishnappa, Rajeev Lakkavalli
    CLINICAL CANCER INVESTIGATION JOURNAL, 2016, 5 (05): : 369 - 373
  • [8] A Case Of Mantle Cell Lymphoma With Pleural Involvement Developing In A Chronic Myeloid Leukemia Patient Receiving Dasatinib Treatment
    Baldovino, B.
    Halabi, N.
    Koirala, A.
    Axiotis, C.
    Hill, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [9] Clinicopathologic Features and Treatment of CD10-Positive Mantle Cell Lymphoma: A Case Report and Review of Literature
    Hino, Christopher
    Pham, Bryan
    Gray, Austin L.
    Wang, Jun
    Castillo, Dan Ran
    Akhtari, Mojtaba
    Liu, Yan
    PATHOLOGY & ONCOLOGY RESEARCH, 2022, 28
  • [10] COST-EFFECTIVENESS ANALYSIS OF AXICABTAGENE CILOLEUCEL, BREXUCABTAGENE AUTOLEUCEL, AND STANDARD OF CARE FOR TREATMENT OF RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
    Ghanem, B.
    Brown, L.
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2022, 25 (07) : S375 - S375
12